It is a pharma private limited company based in Athipattu, Tamil Nadu, India, established in 1989.
1989 | Athipattu, Tamil Nadu, India | ActiveBio Trans Pharmaceuticals Private Limited, a active private limited company, was established on 23 November 1989 in Athipattu, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN1989PTC018382. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Employing 26 professional, Its leadership includes Meda Malleswararao (Director), Ramakrishna Meda (Director), Meda Manjula Rao (Director). Past directors included Ramakrishna Meda, Meda Manjula Rao, Vinay Krishna Meda. It holds no open charges and ₹1.57 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No112 (Old 144/2) Vanagaram Road, Athipattu, Tamil Nadu, 600095.
U24231TN1989PTC018382
018382
23 November 1989
₹1.00 M
₹0.30 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Bio Trans Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meda Malleswararao | Director | 04 Oct 2011 | Current |
| Ramakrishna Meda | Director | 16 Aug 2011 | Current |
| Meda Manjula Rao | Director | 23 Nov 1989 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 08 Aug 2011 | Past |
| Pramod Abcsdd | Managing Director | 18 Aug 2011 | Past |
| Pramod Abcsdd | Director | 16 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bio Trans Pharmaceuticals Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 8.44% decrease. The company also saw a substantial improvement in profitability, with a 58.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 46.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Bio Trans Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,569,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2014 | Andhra Bank | ₹1.57 M | Satisfied |
Explore comprehensive loan charge details -
Bio Trans Pharmaceuticals has a workforce of 26 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bio Trans Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Trans Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bio Trans Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Bio Trans Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge registered on 09 Mar 2014 via Charge ID 10485840 with Andhra Bank was fully satisfied on 20 Mar 2022. was completed.
Progress on A charge with Andhra Bank of Rs. 1.57 M registered on 09 Mar 2014 with Charge ID 10485840 was modified on 06 Feb 2016. was documented.
The activity A charge with Andhra Bank amounted to Rs. 1.57 M with Charge ID 10485840 was registered on 09 Mar 2014. was completed.
Progress on Meda Malleswararao was appointed as a Director was appointed as a Director on 04 Oct 2011 & has been associated with this company since 14 years 2 months . was documented.
The CIN of Bio Trans Pharmaceuticals Private Limited is U24231TN1989PTC018382.
Bio Trans Pharmaceuticals Private Limited is headquartered at New No112 (Old 144/2) Vanagaram Road, Athipattu, Tamil Nadu, 600095.
Bio Trans Pharmaceuticals Private Limited was incorporated on 23 November 1989.
The current directors of Bio Trans Pharmaceuticals Private Limited are
The primary industry of Bio Trans Pharmaceuticals Private Limited is Manufacturing.
Bio Trans Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bio Trans Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Bio Trans Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX